Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-09-18FDA Approved: RHOPRESSA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approves a supplemental application for RHOPRESSA (netarsudil) filed by Alcon Laboratories, Inc.
-
FDA approval · 2024-09-16FDA Approved: IYUZEH — Supplemental Application (Thea Pharma Inc.)
FDA approves a supplemental application for IYUZEH (latanoprost ophthalmic solution 0.005%). This approval expands the product's labeling re…
-
FDA approval · 2024-09-16FDA Approved: TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for TIMOLOL MALEATE (generic) by Somerset Therapeutics, LLC, for ophthalmic use to treat elevated intr…
-
FDA approval · 2024-09-10FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a new original application for a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate for lowering intra…
-
FDA approval · 2024-08-09FDA Approved: BRIMONIDINE TARTRATE — Original Application (Somerset Therapeutics, LLC)
The FDA approved the original application for Brimonidine Tartrate, a generic ophthalmic solution, enabling its sale for lowering intraocula…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-08-07FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Travoprost Ophthalmic Solution 0.004% from Mylan, establishing a generic version of travoprost f…
-
FDA approval · 2024-08-07FDA Approved: TIMOLOL MALEATE — Original Application (Caplin Steriles Limited)
FDA approved Caplin Steriles Limited's original ANDA for Timolol Maleate, a generic eye drop product.
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes [Phase 1]
Clinical trial update for a Phase 1 bioequivalence study in open-angle glaucoma and ocular hypertension, currently recruiting.
-
FDA approval · 2024-07-25FDA Approved: ISTALOL — Supplemental Application (Bausch & Lomb Incorporated)
The FDA approved a supplemental application for ISTALOL (timolol maleate) submitted by Bausch & Lomb Incorporated.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients [Phase 3]
Phase 3 trial comparing T4032, unpreserved bimatoprost 0.01%, to Lumigan 0.01% in patients with ocular hypertension or glaucoma. The study h…
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]
The document reports that the long-term Phase 3 study of STN1012600 in open-angle glaucoma or ocular hypertension has completed.
-
CLINICAL_TRIALS research · 2024-07-12Clinical Trial Update: Efficacy of NSAID vs. Steroid-NSAID Combo Post-Selective Laser Trabeculoplasty: Phase 4, Single-Center RCT [Phase 4]
Phase 4 trial comparing NSAID alone versus a steroid-NSAID combination to manage postoperative inflammation after selective laser trabeculop…
-
FDA approval · 2024-07-12FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION — Original Application (Gland Pharma Limited)
FDA approved a generic travoprost ophthalmic solution (ANDA) from Gland Pharma Limited, expanding access to a prostaglandin analog for reduc…
-
FDA approval · 2024-07-03FDA Approved: TIMOLOL HEMIHYDRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic timolol hemihydrate eye drop for lowering intraocular pressure in adults with glaucoma or ocular hypertension.
-
FDA approval · 2024-07-03FDA Approved: TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for a generic timolol maleate product (ANDA) from Somerset Therapeutics, LLC, for lowering intraocular…
-
CLINICAL_TRIALS research · 2024-06-12Clinical Trial Update: The A D A G I O Study
Update on the ADAGIO Study indicating the trial is not yet recruiting for open-angle glaucoma and ocular hypertension.
-
CLINICAL_TRIALS research · 2024-06-03Clinical Trial Update: Travoprost Intraocular Implant in Conjunction With Cataract Surgery [Phase 3]
A Phase 3 trial update for a travoprost intraocular implant used during cataract surgery for open-angle glaucoma and ocular hypertension; th…
-
FDA approval · 2024-05-28FDA Approved: TIMOLOL GFS — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for TIMOLOL GFS (timolol maleate) submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2024-05-28Clinical Trial Update: A Phase III Multinational Multicenter Investigator-Masked Randomized Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan® in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase III multinational, investigator-masked, active-controlled trial comparing DE-130A with Xalatan (latanoprost) in open-angle glaucoma or…
-
CLINICAL_TRIALS withdrawal · 2024-05-20Clinical Trial Update: Effect of Negative Pressure on Pattern Electroretinography Readings [NA]
A clinical trial examining the effect of negative pressure on pattern electroretinography readings in glaucoma-related conditions has been w…
-
FDA approval · 2024-05-16FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic fixed-dose combination eye drops containing brimonidine tartrate and timolol maleate for reducing intraocula…
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]
Phase 3 trial comparing Bimatoprost Sustained Release (SR) with selective laser trabeculoplasty (SLT) in adults with open-angle glaucoma or …
-
CLINICAL_TRIALS trial_result · 2024-05-10Clinical Trial Update: Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]
Phase 1/2 safety and efficacy study of JV-GL1 in open-angle glaucoma or ocular hypertension has been suspended.
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Intraocular Pressure in Ocular Hypertensives With Scleral Lens Wear [NA]
A Mayo Clinic study evaluating intraocular pressure in ocular hypertensives wearing scleral lenses has been terminated; results were posted …
-
FDA approval · 2024-04-25FDA Approved: BRINZOLAMIDE — Supplemental Application (Oceanside Pharmaceuticals.)
The FDA approved a supplemental application for Brinzolamide submitted by Oceanside Pharmaceuticals. The approval concerns the generic drug …